CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
Evangelos Konstantinidis, A. Molisak, F. Perrin, Linn Streubel-Gallasch +13 more
2022Molecular Therapy: Nucleic Acids43 citations Open access
Semantic Scholar

